Physician profile
Evan Chafitz
NPI 1760549505
$70,099.81
in general payments reported to CMS, 2019-2025
16 companies · $22K in 2025
The $22K reported for 2025 was more than what 99% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,048 · 2020: $7,816 · 2021: $11K · 2022: $9,273 · 2023: $11K · 2024: $6,668 · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $18K · Consulting Fee: $7,500 · Travel and Lodging: $6,034 · Food and Beverage: $4,908 · Gift: $1,472 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,015 · Entertainment: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $18,300.00 |
| Consulting Fee | $7,500.00 |
| Travel and Lodging | $6,034.02 |
| Food and Beverage | $4,907.58 |
| Gift | $1,472.45 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,015.25 |
| Entertainment | $196.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $53,667.98 | 2019-2025 | |
| Dentsply Sirona INC | $4,500.12 | 2021-2024 | Astra Tech Implant System, Primescan Connect |
| Biohorizons Implant Systems INC. | $3,691.54 | 2022-2025 | Biohorizons, Biohorizons Dental Implants |
| Henry Schein, INC. | $3,338.53 | 2019-2025 | |
| Nobel Biocare USA | $1,499.92 | 2019-2023 | Nobelactive |
| A-Dec, INC. | $1,276.00 | 2023-2025 | |
| Patterson Companies, INC. | $750.00 | 2022 | |
| Keystone Dental INC. | $621.27 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $201.39 | 2019-2021 | |
| Envista Holdings Corporation | $172.52 | 2024 | Nobelactive |
| Zimvie INC. | $172.15 | 2022-2025 | |
| Sprintray INC | $114.00 | 2025 | |
| Orapharma, A Division of Bausch Health US, LLC | $35.98 | 2019-2020 | |
| Axogen | $20.97 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $19.20 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Geistlich Pharma, North America, INC. | $18.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Chafitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.